rs1424524492
Variant summary
Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBS1_Supporting
The NM_005076.5(CNTN2):c.358G>A(p.Val120Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000282 in 1,526,322 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005076.5 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- epilepsy, familial adult myoclonic, 5Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- benign adult familial myoclonic epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -3 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005076.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CNTN2 | NM_005076.5 | MANE Select | c.358G>A | p.Val120Ile | missense | Exon 4 of 23 | NP_005067.1 | ||
| CNTN2 | NM_001346083.2 | c.358G>A | p.Val120Ile | missense | Exon 4 of 23 | NP_001333012.1 | |||
| CNTN2 | NR_144350.2 | n.627G>A | non_coding_transcript_exon | Exon 4 of 23 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CNTN2 | ENST00000331830.7 | TSL:1 MANE Select | c.358G>A | p.Val120Ile | missense | Exon 4 of 23 | ENSP00000330633.4 | ||
| CNTN2 | ENST00000640428.1 | TSL:5 | c.358G>A | p.Val120Ile | missense | Exon 4 of 23 | ENSP00000491474.1 | ||
| CNTN2 | ENST00000638378.1 | TSL:5 | c.358G>A | p.Val120Ile | missense | Exon 4 of 23 | ENSP00000492617.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152106Hom.: 1 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000270 AC: 5AN: 185390 AF XY: 0.0000408 show subpopulations
GnomAD4 exome AF: 0.0000277 AC: 38AN: 1374216Hom.: 0 Cov.: 32 AF XY: 0.0000297 AC XY: 20AN XY: 673000 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152106Hom.: 1 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74298 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Epilepsy, familial adult myoclonic, 5 Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 120 of the CNTN2 protein (p.Val120Ile). This variant is present in population databases (no rsID available, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CNTN2-related conditions. ClinVar contains an entry for this variant (Variation ID: 474483). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt CNTN2 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at